AzTrials
AzTrials

Body WeightSUB-POPNCT04567108

Health Effects of Substituting Sugary Beverages With Artificially-sweetened Beverages or Water

A study testing Maintain usual SSBs, Substitute to non-SSBs and Study app in people with Body Weight, run by Brigham and Women's Hospital at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Sugar-sweetened beverages (SSBs) contribute an alarming ~7% of calories in the US diet among adults, making SSBs the single largest source of added sugar. However, whether artificially sweetened beverages are a healthful alternative for reducing SSB intake among habitual SSB consumers is unknown. Read more about this study

Who is it for?
Ages 20 to 69 yearsHealthy volunteers can take part
Conditions the study is for
Body Weight
What is being tested?
Maintain usual SSBs, Substitute to non-SSBs and Study app
Could I receive a placebo?
No, everyone receives an active treatment
How many people
461 participants
Where
1 siteUnited States
Study dates
22 Apr 2021to 21 May 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 69 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Adults aged 20-69 years
  • Consume ≥1 serving/day (12 oz.) of SSBs (SSBs include soda, fruit drinks, energy drinks, sports drinks, and sweetened waters, sweetened with high fructose corn syrup, sucrose, or fruit juices. SSBs do not include 100% fruit juice, sweetened teas, or flavored milk.)
  • BMI 25.0 to 45.0 kg/m2
  • Access to a smartphone and willingness and ability to download study app
  • Willing to consume beverages consistent with any of the 4 possible group assignments for 6 months

Who cannot join

  • Physician diagnosis of T2D or fasting glucose ≥126 mg/dL at in-person screening visit
  • Intention to move away from greater Boston area within 1 year from randomization
  • Major medical illness (known cardiovascular disease, cancer, kidney disease, cirrhosis, etc.)
  • Phenylketonuria (PKU)
  • Medication that may affect weight or other study endpoints
  • Another family or household member participating in the study
  • Pregnant in the past 12 months, currently breastfeeding, or planning to become pregnant during the study period

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Brigham and Women's Hospital

    Boston, Massachusetts, 02215

Other trials in United States

About this study

Official title: SUBstituting With Preferred Options: Health Effects of Substituting Sugar-sweetened Beverages With Non-caloric Beverages in Adults With Overweight and Obesity

Sugar-sweetened beverages (SSBs) contribute an alarming ~7% of calories in the US diet among adults, making SSBs the single largest source of added sugar. However, whether artificially sweetened beverages are a healthful alternative for reducing SSB intake among habitual SSB consumers is unknown. Therefore, the investigators will conduct a 4-arm randomized diet intervention trial to test the effects of substituting SSBs with calorie-free alternatives on body weight and health, among habitual SSB consumers with overweight/obesity.

Read the detailed description

The SUBstituting with Preferred OPtions (SUB-POP) trial, is a parallel-arm randomized controlled trial (RCT) to test the effects of substituting SSBs with non-caloric options on body weight and markers of type 2 diabetes and cardiometabolic health. Eligible adult participants will be randomized to 1 of 4 beverage groups and receive at-home monthly deliveries of beverages for 6 months. In-person clinic visits will be conducted at baseline, 6, and 12 months. After the 6 months of assigned beverage substitution and delivery, all participants will be instructed to substitute SSBs with water only for a final 6-month observational period. In-person clinic visits will collect technician-measured anthropometrics, blood pressure, biospecimen samples (blood, urine, stool [subset]), and assess physical activity, diet, beverage frequency, and taste preference. The SUB-POP app-based assessments and online diet recall will ascertain daily beverage intake, while diet (via 3 24-hour recalls), physical activity, and overall beverage frequency will be collected every 1-3 months. A subset will receive at-home digital scales to transmit daily body weight for energy balance and caloric compensation modeling. SUB-POP is a novel RCT that will enroll adult regular SSB consumers with overweight or obesity to evaluate the effectiveness of substituting SSBs with non-caloric options in a real-world, un-blinded setting. The trial will leverage social media recruitment methods, achieve ≥30% non-White participants, implement innovative intervention delivery, adherence, and data collection tools, and partition the artificially-sweetened beverage (ASB) substitution intervention to the two most common artificial sweetener types (aspartame, sucralose) to explore potential heterogeneity. Whether ASBs, which are largely free of calories and sugar, provide a healthful interim strategy to transition to water among habitual SSB consumers is unknown. Thus, by addressing this large gap in the understanding of how to address a highly prevalent and concerning dietary exposure, the investigators will inform dietary guidelines and clinical recommendations for the prevention of obesity, type 2 diabetes, and cardiometabolic disease risks. The primary outcomes are change in body weight from baseline to 6 months between the 3 beverage substitution groups (aspartame ASBs, sucralose ASBs, and water) vs. the maintain SSBs control group, adjusting for multiple comparisons. The investigators and staff will be blinded to group assignment at outcome assessments. Intention-to-treat analysis will be used.

After 9/1/2023 the 2 ASB intervention groups (sucralose, aspartame) are combined into a single ASB intervention group; participants randomized on or after 9/1/2023 will be randomized to 1 of 3 beverage groups: maintain SSBs (months 0-6; then switch to water months 6-12); switch to ASBs (months 0-6; then switch to water months 6-12); switch to water (months 0-12). The primary outcomes are change in body weight from baseline to 6 months between the 2 beverage substitution groups (ASBs [all ASB intervention groups combined] and water) vs. the maintain SSBs control group, adjusting for multiple comparisons.

Conditions
Body Weight
Being tested
Maintain usual SSBs, Substitute to non-SSBs, Study app, Beverage delivery
Keywords
Prevention, Weight control, Sugar-sweetened beverages, Artificial sweeteners, Water, Beverages
Medical subject headings
Body Weight

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Maintain usual SSBsBehavioural

    Instruction/guidelines to maintain baseline intake of SSBs (months 0-6); then switch to water only (months 6-12)

  • Substitute to non-SSBsBehavioural

    Instruction/guidelines to eliminate SSBs and replace, where possible, with beverages consistent to group assignment (months 0-6); then switch to water only (months 6-12)

  • Study appBehavioural

    Engage with a motivational mobile app to track beverage intake and complete study data collection

  • Beverage deliveryBehavioural

    Select from approved beverages for a monthly at-home delivery (months 0-6)

Study groups in NCT04567108
Study groupRoleWhat they receive
Maintain SSBs (Control)Active comparatorInstruction to maintain baseline intake of SSBs (months 0-6); then switch to water only (months 6-12)
Receives: Behavioral: Maintain usual SSBs; Behavioral: Study app; Behavioral: Beverage delivery
Substitute Aspartame ASBs (participants randomized through 8/31/2023)ExperimentalInstruction/guidelines to eliminate SSBs and replace, where possible with beverages artificially sweetened with aspartame (months 0-6); then switch to water only (months 6-12)
Receives: Behavioral: Substitute to non-SSBs; Behavioral: Study app; Behavioral: Beverage delivery
Substitute Sucralose ASBs (participants randomized through 8/31/2023)ExperimentalInstruction/guidelines to eliminate SSBs and replace, where possible with beverages artificially sweetened with sucralose (months 0-6); then switch to water only (months 6-12)
Receives: Behavioral: Substitute to non-SSBs; Behavioral: Study app; Behavioral: Beverage delivery
Substitute WaterExperimentalInstruction/guidelines to eliminate SSBs and replace with water (months 0-12)
Receives: Behavioral: Substitute to non-SSBs; Behavioral: Study app; Behavioral: Beverage delivery
Substitute ASBs (participants randomized on or after 9/1/2023)ExperimentalInstruction/guidelines to eliminate SSBs and replace, where possible with beverages artificially sweetened with choice of non-nutritive sweeteners such as sucralose or aspartame
Receives: Behavioral: Substitute to non-SSBs; Behavioral: Study app; Behavioral: Beverage delivery

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Weight Change at 6 months

    Change in total body weight calculated as the month 6 weight minus the baseline weight

    Measured: Baseline, Month 6

Secondary outcomes (9)
  1. Waist Circumference Change

    Calculated as month 6 minus baseline value

    Measured: Baseline, Month 6

  2. Sussex Sweet Taste Preference Score Change (0 to 100 where higher score indicates greater liking of sweet taste)

    Calculated as month 6 minus baseline value

    Measured: Baseline, Month 6

  3. Beverage Intake Change (oz/d)

    Calculated as month 6 minus baseline value

    Measured: Baseline, Month 6

  4. Fasting Plasma Glucose Change

    Calculated as month 6 minus baseline value

    Measured: Baseline, Month 6

  5. Fasting Blood Insulin Change

    Calculated as month 6 minus baseline value

    Measured: Baseline, Month 6

  6. HOMA-IR Change

    Calculated as month 6 minus baseline value

    Measured: Baseline, Month 6

  7. HbA1c Change

    Calculated as month 6 minus baseline value

    Measured: Baseline, Month 6

  8. TG/HDL Ratio Change

    Calculated as month 6 minus baseline value

    Measured: Baseline, Month 6

  9. Weight Change Sustainability

    Calculated as month 6 minus baseline value, month 12 minus month 6 value

    Measured: Baseline, Month 6

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Sep 2020
  2. Study start22 Apr 2021
  3. Primary completion21 May 2026
  4. Study completion21 May 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Parallel randomization on a rolling basis to one of 4 interventions; After 9/1/2023 design is modified to 3 parallel interventions, with sucralose and aspartame interventions combined into one ASB substitution arm
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
461 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04567108
Sponsor's protocol ID
2020p002494
Other IDs
1R01DK125803-01
Acronym
SUB-POP
Status last verified
Jul 2026
First submitted
14 Sep 2020
Last updated
17 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Maintain usual SSBs, Substitute to non-SSBs and Study app in people with Body Weight, run by Brigham and Women's Hospital at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Weight Change at 6 months (time frame: Baseline, Month 6). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Jul 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in